Evoq Remedies Ltd Financials
Company Logo

Evoq Remedies Ltd Financial Statement

Evoq Remedies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Evoq Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual11.76
Operating Expenses Annual13.99
Operating Profit Annual0.18
Interest AnnualTBA
Depreciation0.05
Net Profit Annual0.09
Tax Annual0.04

Evoq Remedies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.12
Cash Flow from Operations-14.62
Cash Flow from Investing-0.26
Cash Flow from Financing14.97
Cash Flow at the End0.21

Evoq Remedies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)1.53
PBIT Margin (%)1.11
PBT Margin (%)1.11
Net PROFIT Margin (%)0.77
Return On Networth / Equity (%)0.26
Return On Networth /Employed (%)0.35
Return On Assets (%)0.24
Total Debt / Equity (X)0.06
Asset Turnover Ratio (%)0.32

Evoq Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual0.22
Total Current Assets Annual49.79
Non Current Assets Annual0.22
Total Shareholders Funds Annual44.54
Total Assets Annual50.01

Evoq Remedies Ltd Earning Calls

No Data Availabe

FAQS on Evoq Remedies Ltd Financials

As of Sep 4, 2025, Evoq Remedies Ltd has a market capitalization of 6.37 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Evoq Remedies Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , Evoq Remedies Ltd recorded a total revenue of approximately 11.76 Cr marking a significant milestone in the company's financial performance.

Evoq Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and -0.3% annually, respectively..

Evoq Remedies Ltd's current PE ratio is 70.78.

Evoq Remedies Ltd's ROCE averaged 3.0% from the FY ending March 2023 to 2025, with a median of 2.1%. It peaked at 6.6% in March 2023, reflecting strong capital efficiency over the period..

Evoq Remedies Ltd's latest EBIT is Rs. 0.13 Cr, surpassing the average EBIT of Rs. 1.01 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions